As the European Medicines Agency (EMA) announces final consultations on its clinical trial data policy will begin at the start of May, we take a look at the issues surrounding trial transparency in Europe.
Environmental representatives have emerged triumphant in the latest
round of negotiations over the finer bones of contention of the
European REACH chemicals legislation, due to come in force in April
European parliamentarians have come up with a long list of measures
that the EU needs to take to combat counterfeit drugs, yet track
and trace technologies were noticeably absent from their calls for
EU ministers yesterday agreed on a compromise version of the
controversial new chemicals law, REACH, however environment groups
have condemned the latest changes as a further watering down of the
law in favour of industry.
The rapporteur trying to finesse the controversial REACH
legislation through the European Parliament, Guido Sacconi, has
formulated a compromise that aims to alleviate fears that the
regulations could pose a heavy financial burden...